These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 5511868)

  • 1. [Presence of a plasma antigen indispensable to the stabilization of fibrin in 2 cases on congenital factor XIII deficiency].
    Soria J; Soria C; Samama M; Josso F
    Thromb Diath Haemorrh; 1970 Dec; 24(3):356-60. PubMed ID: 5511868
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hereditary deficiency in factor XIII activity-synthesis of a non-functional protein].
    Duckert F
    Schweiz Med Wochenschr; 1970 Feb; 100(7):328. PubMed ID: 4984094
    [No Abstract]   [Full Text] [Related]  

  • 3. Electroimmunoassay of plasma subunits-a and -s in a case of congenital fibrin stabilizing factor deficiency.
    Barbui T; Cartei G; Chisesi T; Dini E
    Thromb Diath Haemorrh; 1974 Sep; 32(1):124-31. PubMed ID: 4454035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Congenital deficiency of fibrin stabilizing activity. Presence of a protein immunologically analogous to factor XIII].
    Aguercif M; Nigg OM; Lopez JM; Bouvier CA
    Nouv Rev Fr Hematol; 1971; 11(6):841-8. PubMed ID: 4261156
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of intravascular and extravascular coagulation on serum fibrin degradation products in rats.
    Vanstone JC; Khoury NY
    Thromb Diath Haemorrh; 1971; 25(1):142-6. PubMed ID: 4996073
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological studies of coagulation factor XIII.
    Israels ED; Paraskevas F; Israels LG
    J Clin Invest; 1973 Oct; 52(10):2398-403. PubMed ID: 4199604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factor 13 and protein 13].
    Duckert F
    Nouv Rev Fr Hematol; 1970; 10(5):685-90. PubMed ID: 4250291
    [No Abstract]   [Full Text] [Related]  

  • 8. Human factor XIII: fibrin-stabilizing factor.
    Lorand L; Losowsky MS; Miloszewski KJ
    Prog Hemost Thromb; 1980; 5():245-90. PubMed ID: 7422874
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzymatic method for the quantitative determination of factor. XIII. Application to a familial deficiency.
    Janssen CL; Masure R
    Pathol Eur; 1970; 5(3):315-30. PubMed ID: 5477027
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravascular coagulation-fibrinolysis (ICF) syndrome.
    Owen CA; Bowie EJ
    Ann Clin Lab Sci (1971); 1972; 2(1):26-30. PubMed ID: 4263611
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of the action of factor XIII on the structure of fibrin in the normal and pathological states.
    Kleimenov AN; Rozenfel'd MA; Piruzyan LA; Titova MI; Shimkevich LL
    Biol Bull Acad Sci USSR; 1978; 5(5):610-4. PubMed ID: 754811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital dysfibrinogenemia. Report on a new family (fibrinogen "Wiesbaden")].
    Winckelmann G
    Thromb Diath Haemorrh Suppl; 1973; 55():345-56. PubMed ID: 4216115
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic demonstration of a deficiency of Hageman factor-like material in Hageman trait.
    Smink MM; Daniel TM; Ratnoff OD; Stavitsky AB
    J Lab Clin Med; 1967 May; 69(5):819-32. PubMed ID: 4960805
    [No Abstract]   [Full Text] [Related]  

  • 14. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reliability of simple examination methods for the measurement of fibrin stabilization and factor XIII activity].
    Popat D; Weber G; Wenzel E
    Med Welt; 1972 Sep; 23(40):1387-9. PubMed ID: 4655580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of coagulation factor XIII. Critical study of the different techniques used (author's transl)].
    Soria J; Soria C; Lafay P
    Pathol Biol (Paris); 1980 May; 28(5):313-7. PubMed ID: 6770323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor-XIII subunits-A and -S in congenital deficiency and in acute myeloblastic leukemia.
    Barbui T; Rodeghiero F; Dini E
    Haematologica; 1974 Dec; 59(4):458-66. PubMed ID: 4219003
    [No Abstract]   [Full Text] [Related]  

  • 18. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen derivatives. A laboratory and clinical study.
    Vermylen J
    Verh K Vlaam Acad Geneeskd Belg; 1972; 34(2):125-208. PubMed ID: 4278099
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode.
    Hellstern P; Schilz K; von Blohn G; Wenzel E
    Thromb Haemost; 1983 Aug; 50(2):563-6. PubMed ID: 6138878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.